To assess whether ccbl-deficiency in DCs would increase their ability to reject tumors, immune competent C57BL/6 wt mice were subcutaneously injected with OVA-expressing EG.7 lymphoma cells and vaccinated with either wt or ccbl-deficient bone marrow derived DCs (BMDCs). Here, CBL is linked to lymphoma.